Bangladesh Institute of Research and Rehabilitation in Diabetes Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT01589445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders